Prediction of Survival Among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma: A Response‐Based Approach

BACKGROUND AND AIMS: The heterogeneity of intermediate‐stage hepatocellular carcinoma (HCC) and the widespread use of transarterial chemoembolization (TACE) outside recommended guidelines have encouraged the development of scoring systems that predict patient survival. The aim of this study was to b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Hepatology
Autores principales: Han, Guohong, Berhane, Sarah, Toyoda, Hidenori, Bettinger, Dominik, Elshaarawy, Omar, Chan, Anthony W. H., Kirstein, Martha, Mosconi, Cristina, Hucke, Florian, Palmer, Daniel, Pinato, David J., Sharma, Rohini, Ottaviani, Diego, Jang, Jeong W., Labeur, Tim A., van Delden, Otto M., Pirisi, Mario, Stern, Nick, Sangro, Bruno, Meyer, Tim, Fateen, Waleed, García‐Fiñana, Marta, Gomaa, Asmaa, Waked, Imam, Rewisha, Eman, Aithal, Guru P., Travis, Simon, Kudo, Masatoshi, Cucchetti, Alessandro, Peck‐Radosavljevic, Markus, Takkenberg, R.B., Chan, Stephen L., Vogel, Arndt, Johnson, Philip J.
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7496334/
https://ncbi.nlm.nih.gov/pubmed/31698504
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.31022
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares